Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/42008
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBaiocchi, Otavio Carvalho Guimarães [UNIFESP]
dc.contributor.authorColleoni, Gisele Wally Braga [UNIFESP]
dc.contributor.authorNavajas, Eduardo Vitor [UNIFESP]
dc.contributor.authorDuarte, Luiz Cláudio de Carvalho [UNIFESP]
dc.contributor.authorAlves, Antonio Correa [UNIFESP]
dc.contributor.authorAndrade, Ana Lúcia Sampaio Sgambatti de
dc.contributor.authorKerbauy, José [UNIFESP]
dc.contributor.authorOliveira, José Salvador Rodrigues de [UNIFESP]
dc.date.accessioned2018-06-15T12:39:54Z-
dc.date.available2018-06-15T12:39:54Z-
dc.date.issued2002-04-01
dc.identifierhttp://dx.doi.org/10.1080/028418602753669599
dc.identifier.citationActa Oncologica. Oslo: Taylor & Francis As, v. 41, n. 2, p. 192-196, 2002.
dc.identifier.issn0284-186X
dc.identifier.urihttp://repositorio.unifesp.br/11600/42008-
dc.description.abstractTwenty cases of systemic non-Hodgkin's lymphoma (NHL) in HIV-infected patients were reviewed over a 10-year-period, divided into Group A, including 13 NHL cases treated before the highly active antiretroviral therapy (HAART) era, and Group B, including 7 patients who received HAART. A Kaplan-Meier survival curve was performed and log-rank was applied to assess statistical differences between the groups. In group A, the median CD4 count was 36 cells/mm(3). No complete remission was found. In group B, the median CD4 count was 137 cells/mm(3). Four patients (57.0%) are still alive and in complete remission. Group A had a median survival of 5 months and group B 31 months (p = 0.0032). Our results are in agreement with recent reports in that a higher CD4 count and better immune status achieved with HAART is predictive of a better outcome. We found that HAART in combination with chemotherapy improves overall survival of NHL patients without increasing adverse effects.en
dc.format.extent192-196
dc.language.isoeng
dc.publisherTaylor & Francis As
dc.relation.ispartofActa Oncologica
dc.rightsAcesso aberto
dc.titleImpact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphomaen
dc.typeArtigo
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniversidade Federal de Goiás (UFG)
dc.description.affiliationUniv Fed Sao Paulo, Hematol & Transfus Serv, Sao Paulo, Brazil
dc.description.affiliationUniv Fed Sao Paulo, Dept Pathol, Sao Paulo, Brazil
dc.description.affiliationUniv Fed Goias, Dept Epidemiol, Goiania, Go, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo, Hematol & Transfus Serv, Sao Paulo, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo, Dept Pathol, Sao Paulo, Brazil
dc.identifier.doi10.1080/028418602753669599
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000175951000014
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.